Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumours
Crossref DOI link: https://doi.org/10.1007/s00280-016-3071-1
Published Online: 2016-06-13
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goulooze, Sebastiaan C.
Galettis, Peter
Boddy, Alan V.
Martin, Jennifer H.
License valid from 2016-06-13